Conclusions Topics had humoral immunity to SARS-CoV-2 N prior to the pandemic, and early humoral defense responses were seen in approximately 50% of hospitalized severe/critical COVID-19 sufferers in Japan
Conclusions Topics had humoral immunity to SARS-CoV-2 N prior to the pandemic, and early humoral defense responses were seen in…